New nasal spray aims to rapidly reduce suicidal thoughts in severe depression
NCT ID NCT07193901
Summary
This study is testing whether a nasal spray containing a form of ketamine can quickly reduce severe depression symptoms and suicidal thoughts in adults. About 98 participants with major depression and active suicidal thoughts will receive either the spray or a placebo. The main goal is to see if the spray significantly improves depression scores within 24 hours and is safe to use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BEIjing AnDing hospital capital medical university
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Beijing AnDing hospital capital medical university
RECRUITINGBeijing, China
Contact
-
Beijing Huilongguan Hospital
RECRUITINGBeijing, China
Contact
-
Hangzhou Seventh People's Hospital
RECRUITINGHangzhou, China
Contact
Contact
-
Suzhou Guangji Hospital
RECRUITINGSuzhou, China
Contact
-
The Fourth People's Hospital of Chengdu
RECRUITINGChengdu, China
Contact
-
The affiliated Kangning Hospital of Ningbo University
RECRUITINGNingbo, China
Contact
-
The fourth affiliated hospital of Anhui medical university
RECRUITINGHefei, China
Contact
Conditions
Explore the condition pages connected to this study.